Literature DB >> 9824616

Role of NF-kappaB in immune and inflammatory responses in the gut.

M F Neurath1, C Becker, K Barbulescu.   

Abstract

NF-kappaB is a pleiotropic transcription factor with key functions in the intestinal immune system. NF-kappaB family members control transcriptional activity of various promoters of proinflammatory cytokines, cell surface receptors, transcription factors, and adhesion molecules that are involved in intestinal inflammation. The perpetuated activation of NF-kappaB in patients with active inflammatory bowel disease suggests that regulation of NF-kappaB activity is a very attractive target for therapeutic intervention. Such strategies include antioxidants, proteasome inhibitors, inhibition of NF-kappaB by adenoviral I kappaB alpha expression vectors, and antisense DNA targeting of NF-kappaB. These approaches will hopefully permit the design of new treatment strategies for chronic intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824616      PMCID: PMC1727350          DOI: 10.1136/gut.43.6.856

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  71 in total

1.  Involvement of CRAF1, a relative of TRAF, in CD40 signaling.

Authors:  G Cheng; A M Cleary; Z S Ye; D I Hong; S Lederman; D Baltimore
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

2.  RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.

Authors:  B Z Stanger; P Leder; T H Lee; E Kim; B Seed
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

Review 3.  Structure, regulation and function of NF-kappa B.

Authors:  U Siebenlist; G Franzoso; K Brown
Journal:  Annu Rev Cell Biol       Date:  1994

4.  Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators.

Authors:  M L Schmitz; G Stelzer; H Altmann; M Meisterernst; P A Baeuerle
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

5.  Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells.

Authors:  A M Zeiher; B Fisslthaler; B Schray-Utz; R Busse
Journal:  Circ Res       Date:  1995-06       Impact factor: 17.367

6.  Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms.

Authors:  P Wang; P Wu; M I Siegel; R W Egan; M M Billah
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

7.  Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses.

Authors:  W C Sha; H C Liou; E I Tuomanen; D Baltimore
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

8.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family.

Authors:  F Weih; D Carrasco; S K Durham; D S Barton; C A Rizzo; R P Ryseck; S A Lira; R Bravo
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

9.  RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A.

Authors:  M Neumann; T Grieshammer; S Chuvpilo; B Kneitz; M Lohoff; A Schimpl; B R Franza; E Serfling
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

10.  Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter.

Authors:  K L Wright; L C White; A Kelly; S Beck; J Trowsdale; J P Ting
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  85 in total

Review 1.  Anti-TNF antibody treatment of Crohn's disease.

Authors:  S J van Deventer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Nuclear factor kappaB in liver disease.

Authors:  N J Gallagher; L S Young
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

3.  Changes in gut function during hibernation: implications for bowel transplantation and surgery.

Authors:  H V Carey; M J Mangino; J H Southard
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

4.  Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance?

Authors:  Alnoor Ramji; David A Owen; Siegfried R Erb; Charles H Scudamore; Eric M Yoshida
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 5.  Small bowel review: normal physiology part 2.

Authors:  A B Thomson; M Keelan; A Thiesen; M T Clandinin; M Ropeleski; G E Wild
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

6.  Aggressive mucosa associated lymphoid tissue lymphomas are associated with mutations in Bcl10.

Authors:  J Spencer
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

7.  TNF-α induces vectorial secretion of IL-8 in Caco-2 cells.

Authors:  Dennis I Sonnier; Stephanie R Bailey; Rebecca M Schuster; Alex B Lentsch; Timothy A Pritts
Journal:  J Gastrointest Surg       Date:  2010-09-09       Impact factor: 3.452

8.  Protective effect of asiatic acid in an experimental cerulein-induced model of acute pancreatitis in mice.

Authors:  Wenqin Xiao; Weiliang Jiang; Kai Li; Yangyang Hu; Sisi Li; Li Zhou; Rong Wan
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

9.  Application of tissue microarrays to study the influence of dexamethasone on NF-kappaB expression of pancreas in rat with severe acute pancreatitis.

Authors:  Xi Ping Zhang; Ling Zhang; Hong Miao Xu; Yan Ping Xu; Qi Hui Cheng; Jian Mei Wang; Hai Ping Shen
Journal:  Dig Dis Sci       Date:  2007-06-16       Impact factor: 3.199

Review 10.  Endothelium, inflammation, and diabetes.

Authors:  Paresh Dandona
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.